These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3901332)

  • 1. Growth of Candida albicans in dexamethasone-supplemented media.
    Ghannoum M; Burns G; Abu Elteen K
    Sabouraudia; 1985 Aug; 23(4):313-5. PubMed ID: 3901332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of dexamethasone on in vitro growth of Candida albicans.
    Gupta PN; Ichhpujani RL; Bhatia R; Arora DR; Chugh TD
    J Commun Dis; 1982 Dec; 14(4):259-62. PubMed ID: 6764218
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of Candida albicans by methanethiol produced by Brevibacterium linens.
    Lewis BA
    Microbiologica; 1985 Oct; 8(4):387-90. PubMed ID: 3906369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activated lactoferrin's ability to inhibit Candida growth and block yeast adhesion to the vaginal epithelial monolayer.
    Naidu AS; Chen J; Martinez C; Tulpinski J; Pal BK; Fowler RS
    J Reprod Med; 2004 Nov; 49(11):859-66. PubMed ID: 15603095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of farnesol on amino acid incorporation by a wild-type and cell-wall variant strain of Candida albicans.
    Braun PC
    Can J Microbiol; 2005 Aug; 51(8):715-8. PubMed ID: 16234870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of estradiol on Candida albicans growth.
    Gujjar PR; Finucane M; Larsen B
    Ann Clin Lab Sci; 1997; 27(2):151-6. PubMed ID: 9098515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocorticoid-induced alterations of monocyte defense mechanisms against Candida albicans.
    Heidenreich S; Kubis T; Schmidt M; Fegeler W
    Cell Immunol; 1994 Sep; 157(2):320-7. PubMed ID: 8069920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of dexamethasone by Candida albicans.
    Ghannoum MA; Mudher S; Burns G
    Microbios; 1985; 42(168):103-9. PubMed ID: 3889555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Candida albicans by the anaerobic oral flora of mice in vitro.
    Kennedy MJ
    Sabouraudia; 1981 Sep; 19(3):205-8. PubMed ID: 7027476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Mueller-Hinton-agar as a simple medium for the germ tube production of Candida albicans and Candida dubliniensis.
    Rimek D; Fehse B; Göpel P
    Mycoses; 2008 May; 51(3):205-8. PubMed ID: 18399901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of culture media and oxygen partial pressure on growth, morphology and cytology of Candida albicans in vitro].
    Preusser HJ; Rostek H
    Mykosen; 1983 Oct; 26(10):501-12. PubMed ID: 6361550
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of salivary components that induce transition of hyphae to yeast in Candida albicans.
    Leito JT; Ligtenberg AJ; Nazmi K; Veerman EC
    FEMS Yeast Res; 2009 Oct; 9(7):1102-10. PubMed ID: 19799638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The value of the agar dilution method as a screening test for determining the sensitivity of Candida albicans to fluconazole].
    Yücesoy M; Marol S
    Mikrobiyol Bul; 2002; 36(3-4):317-22. PubMed ID: 12838666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth of Candida albicans on artificial D-glucose derivatives.
    Hrmová M; Sturdík E; Kosík M; Gemeiner P; Petrus L
    Z Allg Mikrobiol; 1983; 23(5):303-12. PubMed ID: 6353783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Candida albicans with a commercially prepared germ-tube solution.
    Potter L; Papasian CJ
    Clin Lab Sci; 1991; 4(2):121-2. PubMed ID: 10149414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dimorphism of Candida albicans in the model of continuous flow culture].
    Bernhardt H; Zimmermann K; Knoke M
    Mycoses; 1994; 37 Suppl 1():50-6. PubMed ID: 7854366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rapid differentiation of Candida albicans from other Candida species using its unique germ tube formation at 39 degrees C.
    Kim D; Shin WS; Lee KH; Kim K; Young Park J; Koh CM
    Yeast; 2002 Aug; 19(11):957-62. PubMed ID: 12125052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valinomycin affects the morphology of Candida albicans.
    Watanabe H; Azuma M; Igarashi K; Ooshima H
    J Antibiot (Tokyo); 2005 Dec; 58(12):753-8. PubMed ID: 16506692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of the NRG1 repressor controls species-specific regulation of chlamydospore development in Candida albicans and Candida dubliniensis.
    Staib P; Morschhäuser J
    Mol Microbiol; 2005 Jan; 55(2):637-52. PubMed ID: 15659176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.